On the other hand, we demonstrated that in AXL-low-expressing EGFR-mutated lung cancer cells, osimertinib exposure increased protein expression and phosphorylation of IGF-1R and thereby restored the survival signal mainly via Gab1 and IRS1 to emerge tolerant. Here, AXL is linked to lung cancer.